David Gancberg

1.9k total citations
32 papers, 1.5k citations indexed

About

David Gancberg is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, David Gancberg has authored 32 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 13 papers in Molecular Biology and 8 papers in Genetics. Recurrent topics in David Gancberg's work include HER2/EGFR in Cancer Research (10 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Virus-based gene therapy research (3 papers). David Gancberg is often cited by papers focused on HER2/EGFR in Cancer Research (10 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Virus-based gene therapy research (3 papers). David Gancberg collaborates with scholars based in Belgium, Australia and Finland. David Gancberg's co-authors include Martine Piccart, Angelo Di Leo, Denis Larsimont, Ghizlane Rouas, Marianne Paesmans, Jorma Isola, Alain Verhest, Minna Tanner, Fátima Cardoso and Chantal Bernard-Marty and has published in prestigious journals such as Clinical Cancer Research, American Journal Of Pathology and Annals of Oncology.

In The Last Decade

David Gancberg

31 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Gancberg Belgium 14 1.1k 631 486 374 195 32 1.5k
Rafael Molina Spain 18 1.1k 1.0× 557 0.9× 476 1.0× 473 1.3× 222 1.1× 33 1.7k
P Bertheau France 16 800 0.7× 536 0.8× 287 0.6× 456 1.2× 234 1.2× 35 1.5k
David Peston United Kingdom 15 724 0.7× 546 0.9× 197 0.4× 283 0.8× 175 0.9× 26 1.5k
Ossi R. Köchli Switzerland 10 861 0.8× 773 1.2× 204 0.4× 552 1.5× 247 1.3× 44 1.8k
Kerry Flom United States 7 976 0.9× 522 0.8× 558 1.1× 368 1.0× 170 0.9× 10 1.6k
T Cooke United Kingdom 15 865 0.8× 520 0.8× 526 1.1× 318 0.9× 117 0.6× 25 1.2k
D.W. Miles United Kingdom 24 1.0k 0.9× 616 1.0× 201 0.4× 579 1.5× 295 1.5× 55 1.8k
Holger Dieterich Switzerland 11 793 0.7× 736 1.2× 158 0.3× 579 1.5× 178 0.9× 14 1.6k
Alison Cheung Canada 14 684 0.6× 1.3k 2.1× 146 0.3× 488 1.3× 156 0.8× 26 1.9k
DM Barnes United Kingdom 16 1.3k 1.2× 494 0.8× 439 0.9× 670 1.8× 178 0.9× 18 1.7k

Countries citing papers authored by David Gancberg

Since Specialization
Citations

This map shows the geographic impact of David Gancberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Gancberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Gancberg more than expected).

Fields of papers citing papers by David Gancberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Gancberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Gancberg. The network helps show where David Gancberg may publish in the future.

Co-authorship network of co-authors of David Gancberg

This figure shows the co-authorship network connecting the top 25 collaborators of David Gancberg. A scholar is included among the top collaborators of David Gancberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Gancberg. David Gancberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gancberg, David. (2017). Twenty Years of European Union Support to Gene Therapy and Gene Transfer. Human Gene Therapy. 28(11). 951–953. 4 indexed citations
2.
Julkowska, Daria, Christopher P. Austin, Christine M. Cutillo, et al.. (2017). The importance of international collaboration for rare diseases research: a European perspective. Gene Therapy. 24(9). 562–571. 60 indexed citations
3.
Gancberg, David, Arnd Hoeveler, & Ruxandra Draghia‐Akli. (2015). Introduction: Gene Therapy and Gene Transfer Projects of the 7th Framework Programme for Research and Technological Development of the European Union (Second Part). PubMed. 26(2). 77–77. 8 indexed citations
4.
Gancberg, David, Arnd Hoeveler, Alessandra Cadete Martini, & Ruxandra Draghia‐Akli. (2015). Opportunities for vaccine research in Europe. Human Vaccines & Immunotherapeutics. 11(8). 1917–1920. 1 indexed citations
5.
Gancberg, David & Ruxandra Draghia‐Akli. (2014). Gene and Cell Therapy Funding Opportunities in Horizon 2020: An Overview for 2014–2015. Human Gene Therapy. 25(3). 175–177. 4 indexed citations
6.
Rousseau, François, David Gancberg, Heinz Schimmel, et al.. (2009). Considerations for the development of a reference method for sequencing of haploid DNA – an opinion paper on behalf of the IFCC Committee on Molecular Diagnostics. International Federation of Clinical Chemistry and Laboratory Medicine. Clinical Chemistry and Laboratory Medicine (CCLM). 47(11). 1343–50. 6 indexed citations
7.
Galmarini, Carlos M., Isabelle Treilleux, Fátima Cardoso, et al.. (2008). Class III β-Tubulin Isotype Predicts Response in Advanced Breast Cancer Patients Randomly Treated Either with Single-Agent Doxorubicin or Docetaxel. Clinical Cancer Research. 14(14). 4511–4516. 55 indexed citations
8.
Gancberg, David, et al.. (2008). Certification of reference materials for detection of the human prothrombin gene G20210A sequence variant. Clinical Chemistry and Laboratory Medicine (CCLM). 46(4). 463–9. 4 indexed citations
9.
Partis, Lina, Malcolm Burns, Koichi Chiba, et al.. (2007). A study of comparability in amplified fragment length polymorphism profiling using a simple model system. Electrophoresis. 28(18). 3193–3200. 4 indexed citations
10.
Leo, Angelo Di, David Gancberg, Denis Larsimont, et al.. (2002). HER-2 amplification and topoisomerase IIalpha gene aberrations as predictive markers in node-positive breast cancer patients randomly treated either with an anthracycline-based therapy or with cyclophosphamide, methotrexate, and 5-fluorouracil.. PubMed. 8(5). 1107–16. 216 indexed citations
11.
Larsimont, Denis, Angelo Di Leo, Ghizlane Rouas, et al.. (2002). HER-2/neu evaluation by immunohistochemistry and fluorescence in situ hybridization in breast cancer: implications for daily laboratory practice.. PubMed. 22(4). 2485–90. 11 indexed citations
12.
Gancberg, David, Angelo Di Leo, Fátima Cardoso, et al.. (2002). Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites. Annals of Oncology. 13(7). 1036–1043. 259 indexed citations
13.
Gancberg, David, Angelo Di Leo, G. Rouas, et al.. (2002). Reliability of the tissue microarray based FISH for evaluation of the HER-2 oncogene in breast carcinoma. Journal of Clinical Pathology. 55(4). 315–317. 40 indexed citations
14.
Gancberg, David, Tero A.H. Järvinen, Angelo Di Leo, et al.. (2002). Evaluation of HER-2/NEU Protein Expression in Breast Cancer by Immunohistochemistry: An Interlaboratory Study Assessing the Reproducibility of HER-2/NEU Testing. Breast Cancer Research and Treatment. 74(2). 113–120. 59 indexed citations
15.
Cardoso, Fátima, Angelo Di Leo, Denis Larsimont, et al.. (2001). Bcl-2 as a predictive marker for tamoxifen responsiveness in the adjuvant setting of node-positive breast cancer. Breast Cancer Research and Treatment. 69(3). 243. 2 indexed citations
16.
Cardoso, Fátima, Angelo Di Leo, Denis Larsimont, et al.. (2001). Evaluation of HER2, p53, bcl-2, topoisomerase II-α, heat shock proteins 27 and 70 in primary breast cancer and metastatic ipsilateral axillary lymph nodes. Annals of Oncology. 12(5). 615–620. 72 indexed citations
17.
Gancberg, David, Francesco Feoli, J. Hamels, et al.. (2000). Trisomy 6 in Merkel cell carcinoma: a recurrent chromosomal aberration. Histopathology. 37(5). 445–451. 26 indexed citations
18.
Tanner, Minna, David Gancberg, Angelo Di Leo, et al.. (2000). Chromogenic in Situ Hybridization. American Journal Of Pathology. 157(5). 1467–1472. 285 indexed citations
19.
Lespagnard, Laurence, David Gancberg, G. Rouas, et al.. (1999). Tumor-infiltrating dendritic cells in adenocarcinomas of the breast: a study of 143 neoplasms with a correlation to usual prognostic factors and to clinical outcome. International Journal of Cancer. 84(3). 309–314. 88 indexed citations
20.
Gancberg, David, Alain Kentos, Jean‐Louis Dargent, et al.. (1999). Trisomy 21 as the Sole Abnormality in a Refractory Anemia with Ring Sideroblasts. Cancer Genetics and Cytogenetics. 113(2). 180–182. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rafael Molina Breakdown of academic impact, for papers by P Bertheau Breakdown of academic impact, for papers by David Peston Breakdown of academic impact, for papers by Ossi R. Köchli Breakdown of academic impact, for papers by Kerry Flom Breakdown of academic impact, for papers by T Cooke Breakdown of academic impact, for papers by D.W. Miles Breakdown of academic impact, for papers by Holger Dieterich Breakdown of academic impact, for papers by Alison Cheung Breakdown of academic impact, for papers by DM Barnes
Rankless by CCL
2026